Mitochondrial toxicity. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Mitochondria Mitochondria, Liver Liver Cells, Cultured Cell Line, Tumor Kidney Cell Line

Organisms2

Rats, Sprague-Dawley Rats, Inbred F344

Diseases26

Acidosis, Lactic HIV-Associated Lipodystrophy Syndrome Mitochondrial Diseases HIV Infections Neoplasms Leukopenia Drug-Related Side Effects and Adverse Reactions Radiation Injuries Drug-Induced Liver Injury Neutropenia Hematologic Diseases Lung Neoplasms Thrombocytopenia Nausea Neurotoxicity Syndromes Body Weight Neoplasm Metastasis Plant Poisoning Neoplasm Recurrence, Local Stomatitis Breast Neoplasms Adenocarcinoma Abnormalities, Drug-Induced Vomiting Carcinoma, Non-Small-Cell Lung Drug Eruptions

Chemicals and Drugs56

Stavudine DNA, Mitochondrial Reverse Transcriptase Inhibitors Zalcitabine Arabinofuranosyluracil Cephaloglycin Didanosine Purine Nucleosides Anti-HIV Agents Zidovudine Equilibrative Nucleoside Transporter 1 Lactic Acid Electron Transport Complex II Electron Transport Complex IV Organophosphonates Antiviral Agents DNA-Directed DNA Polymerase Antineoplastic Agents Cisplatin Fluorouracil Doxorubicin Deoxycytidine Antineoplastic Agents, Phytogenic Antimetabolites, Antineoplastic Paclitaxel Antidotes Camptothecin Cyclophosphamide Carboplatin Taxoids Teratogens Organoplatinum Compounds Water Pollutants, Chemical Leucovorin Etoposide Environmental Pollutants Glutathione Insecticides Vinblastine Methotrexate Antineoplastic Agents, Alkylating Plant Extracts Vincristine Antibiotics, Antineoplastic Antibodies, Monoclonal Acetaminophen Prodrugs Ifosfamide Cadmium Methylmercury Compounds Dacarbazine Aluminum Cytochrome P-450 CYP2E1 Neurotoxins Dihydrouracil Dehydrogenase (NADP)Drug Carriers

Analytical, Diagnostic and Therapeutic Techniques and Equipment35

Antiretroviral Therapy, Highly Active Toxicity Tests Toxicity Tests, Acute Lethal Dose 50 Antineoplastic Combined Chemotherapy Protocols Toxicity Tests, Chronic Drug Administration Schedule Treatment Outcome Infusions, Intravenous No-Observed-Adverse-Effect Level Maximum Tolerated Dose Administration, Oral Combined Modality Therapy Drug Evaluation Toxicity Tests, Subchronic Survival Analysis Disease-Free Survival Radiotherapy Dosage Drug Evaluation, Preclinical Survival Rate Animal Testing Alternatives Radiotherapy Organ Size Toxicity Tests, Subacute Dose Fractionation Body Weight Radiotherapy, Conformal Area Under Curve Neoplasm Staging Remission Induction Injections, Intravenous Salvage Therapy Radioimmunotherapy Clinical Trials, Phase I as Topic Drug Carriers

Phenomena and Processes17

Dose-Response Relationship, Drug Lethal Dose 50 No-Observed-Adverse-Effect Level Cell Survival Maximum Tolerated Dose Time Factors Drug Interactions Organ Size Body Weight Area Under Curve Oxidative Stress Apoptosis Tissue Distribution Drug Synergism Cell Death Biotransformation Metabolic Detoxication, Drug

Disciplines and Occupations1

Technology, Industry, Agriculture1

Information Science2

Survival Rate Radiotherapy, Conformal

Health Care7

Treatment Outcome Radiation Injuries Survival Analysis Disease-Free Survival Survival Rate Area Under Curve Clinical Trials, Phase I as Topic

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Stavudine Acidosis, Lactic DNA, Mitochondrial Reverse Transcriptase Inhibitors Zalcitabine Arabinofuranosyluracil Cephaloglycin HIV-Associated Lipodystrophy Syndrome Didanosine Purine Nucleosides Mitochondria Anti-HIV Agents Mitochondrial Diseases Zidovudine Equilibrative Nucleoside Transporter 1 Lactic Acid Electron Transport Complex II Mitochondria, Liver Electron Transport Complex IV HIV Infections Antiretroviral Therapy, Highly Active Organophosphonates Antiviral Agents DNA-Directed DNA Polymerase Toxicity Tests Toxicity Tests, Acute Dose-Response Relationship, Drug Lethal Dose 50 Antineoplastic Combined Chemotherapy Protocols Toxicity Tests, Chronic Drug Administration Schedule Antineoplastic Agents Treatment Outcome Cisplatin Infusions, Intravenous No-Observed-Adverse-Effect Level Fluorouracil Cell Survival Maximum Tolerated Dose Neoplasms Administration, Oral Doxorubicin Combined Modality Therapy Time Factors Toxicology Deoxycytidine Drug Evaluation Leukopenia Antineoplastic Agents, Phytogenic Drug-Related Side Effects and Adverse Reactions Antimetabolites, Antineoplastic Radiation Injuries Paclitaxel Drug-Induced Liver Injury Liver Neutropenia Toxicity Tests, Subchronic Antidotes Survival Analysis Camptothecin Cyclophosphamide Disease-Free Survival Radiotherapy Dosage Carboplatin Hematologic Diseases Lung Neoplasms Taxoids Teratogens Drug Evaluation, Preclinical Survival Rate Organoplatinum Compounds Water Pollutants, Chemical Leucovorin Thrombocytopenia Etoposide Animal Testing Alternatives Environmental Pollutants Glutathione Rats, Sprague-Dawley Insecticides Vinblastine Methotrexate Radiotherapy Antineoplastic Agents, Alkylating Drug Interactions Organ Size Cells, Cultured Nausea Toxicity Tests, Subacute Neurotoxicity Syndromes Plant Extracts Dose Fractionation Vincristine Body Weight Antibiotics, Antineoplastic Nanoparticles Radiotherapy, Conformal Antibodies, Monoclonal Area Under Curve Cell Line, Tumor

No FAQ available that match "mitochondrial toxicity"